Cargando…
DCM Support: cell therapy and circulatory support for dilated cardiomyopathy patients with severe ventricular impairment
AIMS: The DCM Support trial (NCT03572660) uses a percutaneous circulatory support device (Impella CP, Abiomed, Danvers, MA, USA) to improve the safety of an intracoronary cell infusion procedure in patients with dilated cardiomyopathy (DCM) and a severely reduced left ventricular ejection fraction (...
Autores principales: | Reid, Alice, Hussain, Mohsin, Veerapen, Jessry, Ramaseshan, Rohini, Hall, Russell, Bowles, Ruth, Jones, Daniel A., Mathur, Anthony |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10375109/ https://www.ncbi.nlm.nih.gov/pubmed/37190883 http://dx.doi.org/10.1002/ehf2.14393 |
Ejemplares similares
-
Case report: Cytokine therapy and an intracoronary autologous bone marrow-derived cell infusion with Impella support in a patient with dilated cardiomyopathy and a severely reduced ejection fraction
por: Hall, Russell Charles, et al.
Publicado: (2022) -
Influence of Mechanical Circulatory Support on Endothelin Receptor Expression in Human Left Ventricular Myocardium from Patients with Dilated Cardiomyopathy (DCM)
por: Gärtner, Florian, et al.
Publicado: (2017) -
Left ventricular clot: Newly known increased complication of air pollution in dilated cardiomyopathy (DCM)
por: Alizadehasl, Azin, et al.
Publicado: (2020) -
Cardiac-Specific Cre Induces Age-Dependent Dilated Cardiomyopathy (DCM) in Mice
por: Rehmani, Taha, et al.
Publicado: (2019) -
Bridge to recovery in two cases of dilated cardiomyopathy after long-term mechanical circulatory support
por: Pacholewicz, Jerzy, et al.
Publicado: (2014)